Quantiferon tb gold test

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

IGRA; Interferon gamma release assay

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Highly sensitive immunological test for tuberculosis screening. The tuberculosis-specific antigens ESAT-6 (early secretory antigen target-6), CFP-10 (culture filtrate protein 10) and TB 7.7 (p4) are used, which are only found in M. tuberculosis and M. bovis. These antigens are absent in all strains used for BCG vaccines and in most non-tuberculous mycobacteria (atypical mycobacteria) except M. kansasii, M. marinum, M. szulgai and M. flavescens. The interferon-γ formation of T-effector cells stimulated with the above-mentioned antigens specific for M. tuberculosis is detected.

General informationThis section has been translated automatically.

The sensitivity of this test system is stated to be about 90% (for comparison tuberculin skin test: < 70%) with a specificity of 98%. In addition, the general stimulability of T-lymphocytic IFN-γ formation is investigated to prevent false negative test results. In this way, a statement regarding the T-cell-mediated immunity situation is also possible.

IndicationThis section has been translated automatically.

  • Environmental investigation of contact persons in proven cases of open TB.
  • Screening of healthcare workers for previous TB infection.
  • Detection of active tuberculosis before starting immunosuppressive therapy, e.g. when using biologicals or methotrexate for the treatment of psoriasis and rheumatic diseases.
  • Screening of immunosuppressed patients taking into account the number of CD4 cells.

Note(s)This section has been translated automatically.

  • The test tubes are coated with a combination of these antigens that stimulate the T cells in the patient's whole blood sample. Upon prior contact with M. tuberculosis, the T cells release interferon-γ into the plasma. Interferon gamma is measured by ELISA tests. This is used to assess the probability of TB infection.

    Notice!

    The test is not affected by a previous BCG vaccination. Considering the controls, the test can also be used in patients with immunodeficiency (e.g. HIV).
  • For this test, special collection tubes are necessary, which are provided free of charge by the laboratories on request. Do not refrigerate or freeze the samples; storage and transport of samples is at room temperature. If proper incubation is possible on site, this should be attempted; information is available from the laboratory. Contact addresses: Dr. A.-M. Fahr; Dr. A. Turnwald-Maschler; Dr. M. Holfelder: Tel.: 06221-3432-125/262/234

LiteratureThis section has been translated automatically.

  1. Detjen A et al (2006). Immunological diagnostics of tuberculosis interferon γ tests. monthly journal Kinderheilkd 154: 152-159
  2. Ewer K et al(2003) Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361:1168-1173
  3. Hauer B et al.(2006) Interferon-γ tests in tuberculosis diagnostics - Current status. Pneumology 60: 29-44.
  4. Lange C et al.(2006). Current status of tuberculosis diagnostics. Dtsch Med weekly 131: 341-347

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer